Generic Semaglutide Pens

Semaglutide is a GLP-1 medication that is commonly associated with popular brand names that contain it – such as Ozempic and Rybelsus. This medication is used to help patients with the treatment of issues like type 2 diabetes and to reduce the likelihood of patients in this category developing major cardiovascular issues. These medications are also associated with helping patients with chronic weight management (like the brand-name Wegovy). However, generic semaglutide is not yet approved for obesity treatment (it may be prescribed this way off-label). Generic semaglutide is now available for purchase in Canada. There are already thousands of patients filling their prescriptions at Insulin Outlet. Patients doing so can get semaglutide pens and other similar medications from licensed Canadian pharmacy partners and receive up to 80% savings compared to typical U.S. prices. This helps make essential medications more affordable to those who need them.

Generic semaglutide is a GLP-1 receptor agonist medication that works in the same way as the popular name-brand version Ozempic. This medication is prescribed to patients for type 2 diabetes treatment and comes in the form of a weekly injection. It works by helping the patient gain better glycemic control and may also be able to help patients reduce the risk of major cardiovascular events when combined with a proper diet and exercise routine. This medication is also known to support weight and may sometimes be prescribed off-label for this use by some doctors. This generic medication is still not available for purchase within the U.S. However, it is now approved and being sold by a couple of different manufacturers in Canada.

• This medication is helpful for patients with type 2 diabetes since it lowers glucose by increasing insulin release when blood sugar is high and reducing glucagon
• Weight loss is often a secondary effect of this medication since it reduces appetite and slows down the emptying of the stomach
• Some products may also reduce major cardiovascular events in people with type 2 diabetes and known heart disease
• Generic semaglutide uses the same ingredients as popular medication brands like Ozempic and has similar effectiveness at a lower cost

Both companies making the generic version of semaglutide in Canada so far – Apotex and Dr. Reddy’s Laboratories – have the medication available in 2 mg and 4 mg pen strengths. The 2 mg pens of this medication are designed with the ability to deliver either 0.25 mg or 0.5 mg doses. The 4 mg pens provide 1 mg doses. The 0.25 mg doses are usually only used to help patients get used to the medication before future dose increases (which take place at least four weeks apart). These doses are also designed to be taken once per week.

Semaglutide pens are given to patients in the form of a once-weekly subcutaneous injection. These injections include the dose prescribed by the healthcare provider – which should match the strength listed on the pen. Patients should check with their doctor and the packaging for specific administration instructions. However, the correct administration process is usually as follows:

Multi-Dose Pen Instructions

1. Wash hands thoroughly using soap and warm water for at least 20 seconds before handling the pen
2. Remove the cap of the pen and take a close look at the medication through the viewing window of the deviceNote: The liquid should appear clear and free of particles. Do not use the pen if the solution has a cloudy appearance, appears discolored, or contains debris.
3. Attach a fresh needle to the pen and carefully take off both needle caps (a new needle should be used for every injection)
4. Complete the priming process if it is the first time using this pen (this can be done by turning the dose selector to the flow check symbol, holding the pen with the needle pointing upward, and pressing the injection button until a small drop appears at the needle tip)
5. Turn the dose selector until the dose that was prescribed by the doctor is visible in the dose window and confirm the correct dose before injecting
6. Clean the selected injection site (which should be rotated each time) with an alcohol swab and allow the skin to dry fully
7. Gently pinch the skin and insert the needle straight into the injection site (this should be done at a 90-degree angle)
8. Release the skin after the needle is inserted
9. Press and hold the injection button until the dose counter returns to “0” and keep the button pressed for at least 6 additional seconds to help make sure that the full dose is delivered
10. Remove the needle from the skin by pulling it straight out
11. Carefully place the outer needle cap back onto the needle
12. Carefully unscrew the needle from the pen and dispose of it in an approved sharps container
13. Replace the pen cap after use

Single-Dose Pen Instructions

1. Wash hands well with soap and water before preparing the injection
2. Check the medication through the pen window and confirm the expiration date (the solution should appear clear and colorless)
3. Clean the injection area with an alcohol swab and give the skin time to dry completely
4. Pull off the pen cap (avoid touching the needle guard or attempting to place the cap back on the pen)
5. Position the pen firmly against the skin (this should be done at a 90-degree angle) and press down until the injection starts
6. A clicking sound may be heard once the injection initiates
7. Keep the pen pressed against the skin until the indicator bar stops moving (be patient as the injection process may take several seconds to finish)
8. Lift the pen straight away from the skin once the injection is complete (the needle shield will automatically cover the needle)
9. Dispose of the used pen in an FDA-approved sharps disposal container

The patient should never share needles or injection devices with anyone else. Inject the medication only into approved areas of the body. These areas include the abdomen (at least 2 inches away from the waist), the upper arm, or the thigh.

Boxed Warning

Semaglutide carries an FDA boxed warning about a possible risk of thyroid cancer. It is not known whether semaglutide causes thyroid cancer in humans. However, animal studies showed an increased risk of thyroid tumors during treatment. Semaglutide is not to be taken by any individuals who have either a personal or family history of medullary thyroid carcinoma because of this potential risk. The same goes for patients with multiple endocrine neoplasia syndrome type 2 – a genetic condition linked to thyroid cancer. Patients using semaglutide should contact their healthcare provider if symptoms such as a lump in the neck, trouble swallowing, or persistent hoarseness develop. Additional testing may be recommended if thyroid-related symptoms occur.

Patients taking these medications will also have to keep a few other precautions in mind during their treatment. Pancreatitis has been reported in some rare cases of patients using this medication, and any patients suspecting they may have pancreatitis while taking this medication should stop taking it immediately. Do not resume the treatment if it is confirmed. Patients with a history of diabetic retinopathy will also need extra close monitoring if they are using this medication since this medication can also lead to this condition.

The use of this medication alongside an insulin secretagogue or insulin can increase the risk of hypoglycemia development. This is why patients prescribed a combination of any of these medications should talk to their doctor first to make sure any necessary dosing adjustments are made ahead of time. Some of the side effects of semaglutide can lead to volume depletion and dehydration. Patients with these issues should also be closely monitored since this could turn into acute kidney injury.

Patients with any known hypersensitivity reactions to any of the ingredients in the medication should refrain from taking it. Patients should also seek immediate medical attention if a hypersensitivity reaction is suspected. Gallbladder studies are indicated for any patients with suspected cholelithiasis or cholecystitis who are taking this medication.

Patients should inform clinicians before procedures because semaglutide delays gastric emptying. Patients should also let their healthcare provider know about any other oral medications that they are currently taking since semaglutide slows gastric emptying and may impact the effectiveness of those medications.

Common Side Effects

Patients taking semaglutide commonly experience some side effects – especially when they are just starting the medication or during dose increases. The most frequently reported side effects include those such as:

• Nausea or stomach pain
• Vomiting or diarrhea
• Constipation
• Headache
• heartburn/burping
• Sore throat
• Runny nose

Most of these side effects should resolve on their own as the patient gets used to the medication. Let a doctor know if any of these symptoms are persistent or worsen over time.

Severe Side Effects

There are also some rare cases where patients taking this medication may experience serious side effects. These effects can indicate a more serious problem and require immediate medical attention. This includes effects such as:

• Severe stomach or intestinal issues
• Changes in vision
• Rapid or pounding heartbeat
• Decreased urination
• Swelling in the legs, feet, or ankles
• Swelling of the face, mouth, or throat
• Pain in the upper stomach
• Yellowing of the skin or eyes, fever, or clay-colored stools (this may indicate gallbladder problems)
• Rash/itching
• Difficulty breathing or swallowing
• Any signs of kidney problems (more common with dehydration from loss of fluids while using the medication)
• Serious allergic reactions
• Persistent pain in the upper or middle stomach that may spread to the back and be accompanied by or without vomiting (this may indicate pancreatitis)

Patients experiencing any of these issues should seek immediate medical attention.

Missed semaglutide doses should be taken as soon as they are remembered as long as no more than five days have passed since the dose was initially supposed to be taken. The regular dosing schedule should then be resumed after this. Patients should just skip the missed dose entirely if more than five days have passed since its initial scheduled time and then take the next scheduled dose at its regular time. Doses of this medication should never be doubled and patients who overdose on this medication should call their local poison help line. Those experiencing any side effects of an overdose – like collapsing/seizure or difficulty breathing – should call for emergency medical services immediately.

Store the pens inside of the refrigerator between temperatures of 36°F and 46°F (2°C to 8°C). These products may also be safely stored at room temperature up to 86°F (30°C) for varying amounts of time based on brand and formulation (check with doctor and packaging for more specific details). Do not return the medication to the refrigerator once stored at room temperature.

Patients buying their medication from Insulin Outlet experience:

• Up to 80% savings on their medication’s U.S. prices
• Real medications from licensed Canadian pharmacies
• Flat $29.99 cold shipping
• Medications and services with a 4.9-star average rating from more than 4,000 users

Buy generic semaglutide pens from Canada today.